PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA

Clinical trials for PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA trials appear

Sign up with your email to follow new studies for PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental vaccine aims to boost immune attack on myeloma cells

Disease control Ongoing

This early-stage study tests whether a vaccine made from a protein called survivin can safely help the immune system fight multiple myeloma. About 18 adults whose myeloma has partially responded to initial treatment will receive the vaccine along with standard lenalidomide mainte…

Matched conditions: PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA

Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated May 17, 2026 07:18 UTC

PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA

Get alerted when new PARTIAL RESPONSE OF MULTIPLE MYELOMA OR PLASMA CELL LEUKEMIA trials appear

Experimental vaccine aims to boost immune attack on myeloma cells